| 000 | 01325 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250517130928.0 | ||
| 264 | 0 | _c20170208 | |
| 008 | 201702s 0 0 eng d | ||
| 022 | _a1538-3598 | ||
| 024 | 7 |
_a10.1001/jama.2016.17173 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGupta, Arjun | |
| 245 | 0 | 0 |
_aRepeat Clostridium difficile Testing. _h[electronic resource] |
| 260 |
_bJAMA _c12 2016 |
||
| 300 |
_a2422-2423 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aAbdominal Pain _xetiology |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xadverse effects |
| 650 | 0 | 4 |
_aAnti-Infective Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAzithromycin _xadverse effects |
| 650 | 0 | 4 |
_aBacterial Proteins _xanalysis |
| 650 | 0 | 4 |
_aBacterial Toxins _xanalysis |
| 650 | 0 | 4 |
_aClostridioides difficile _xisolation & purification |
| 650 | 0 | 4 |
_aDiarrhea _xetiology |
| 650 | 0 | 4 |
_aEnterocolitis, Pseudomembranous _xchemically induced |
| 650 | 0 | 4 |
_aEnterotoxins _xanalysis |
| 650 | 0 | 4 |
_aFeces _xmicrobiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMetronidazole _xtherapeutic use |
| 700 | 1 | _aKhanna, Sahil | |
| 773 | 0 |
_tJAMA _gvol. 316 _gno. 22 _gp. 2422-2423 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1001/jama.2016.17173 _zAvailable from publisher's website |
| 999 |
_c26693013 _d26693013 |
||